We have established glycosylation technologies with human-type oligosaccharides, and now, we are developing some drug candidates using our technologies.
Headquarters:
Japan
Company Type:
MNC / Large Enterprise
Company size:
501-1,000 Employees
Address:
null
HIGH
spending power